🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oppenheimer sets $135 target for Integer shares, cites growth potential

Published 15/07/2024, 21:26
ITGR
-

On Monday, Oppenheimer initiated coverage on Integer Holdings Corporation (NYSE:ITGR), a prominent player in the medical device outsourcing industry. The firm issued an Outperform rating with a price target of $135.00, highlighting the company's strong market position and expertise in the sector.

Integer Holdings is recognized for its comprehensive services to original equipment manufacturers (OEMs), offering support throughout the entire product lifecycle, from initial concept to full-scale commercialization. Oppenheimer's price target is based on 2.5 times the estimated 2025 revenue, which is approximately a 38% discount compared to the current MedTech market valuation.

The analyst pointed out that Integer's diverse portfolio of blue-chip customers, including Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), Abbott, and Johnson & Johnson, provides a stable foundation for the company. Notably, 70% of Integer's contracts are long-term, offering a degree of protection against market fluctuations and contributing to the company's robust risk management strategy.

Oppenheimer's positive outlook for Integer Holdings is rooted in three key areas: the diversified nature of the company's risk and reward profile, its specialized core competencies, and the anticipated improvements in its profit and loss statements.

Integer's role as a market leader in medical device outsourcing allows it to indirectly benefit from growth in various segments of the healthcare industry. The firm's endorsement reflects confidence in Integer's ability to maintain its competitive edge and capitalize on opportunities within the MedTech space.

InvestingPro Insights

Integer Holdings Corporation (NYSE:ITGR) is currently attracting attention with its robust financial performance and strategic market positioning. According to recent InvestingPro data, the company boasts a market capitalization of $4.02 billion and a healthy revenue growth of 13.07% over the last twelve months as of Q1 2024. This growth is complemented by a gross profit margin of 26.6%, underscoring Integer's ability to maintain profitability amidst competitive industry dynamics.

InvestingPro Tips indicate that Integer is trading at a low P/E ratio relative to near-term earnings growth, with an adjusted P/E ratio of 32.86 for the last twelve months as of Q1 2024. Additionally, the company is seen as a solid performer with low price volatility, which could appeal to investors looking for stable returns. With liquid assets that exceed short-term obligations, Integer demonstrates a strong balance sheet, which is fundamental for sustaining operations and investing in future growth.

For readers seeking further insights and analysis, there are additional InvestingPro Tips available on Integer Holdings, which can be accessed through the dedicated page at https://www.investing.com/pro/ITGR. Investors may also take advantage of the special offer using the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, providing them with a wealth of resources to make informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.